Duality Biologics has begun (PDF) offering stock, wading into a market reeling from Presid | Duality Biologics has begun ...

An antibody-drug conjugate (ADC) that GSK licensed from China's Hansoh Pharma in a $1.7 billion deal last year has been given breakthrough status by the FDA. The coveted designation for GSK5764227 ...

GSK has turned to China’s Hansoh Pharma to add another antibody-drug conjugate (ADC) to its oncology pipeline, this time licensing a B7-H3-targeting candidate for $185 million upfront.

A special congressional committee has recommended a $15 billion investment to boost the United States' biotech advantage over ...

German scientist Paul Ehrlich introduced a groundbreaking concept to the world: chemical compounds could be engineered to ...

Datroway targets TROP2, the same cancer protein addressed by Trodelvy, a Gilead Sciences ADC also approved for breast cancer. Results from the Phase 3 DREAMM-7 study show GSK drug Blenrep is ...

Steen Lisby, M.D., D.MSc. joins as Chief Medical OfficerJesper Valbjørn, M.Sc. joins as Senior Vice President CMCOngoing team expansion at Myricx ...